1. Home
  2. ‘Hindi not our mother tongue, don’t incite us’: Raj Thackeray’s party on draft education

‘Hindi not our mother tongue, don’t incite us’: Raj Thackeray’s party on draft education

Agencies
June 3, 2019

Mumbai, Jun 3: Joining ranks with the recent protests over the pan-India three language formula proposed in the draft National Education Policy 2019, Maharashtra Navnirman Sena on Sunday spoke against enforcement of Hindi asserting that it is not their mother tongue.

The official Twitter handle of MNS, quoted state leader and spokesperson Anil Shidore as stating “Hindi is not our mother tongue, do not enforce it on us and incite us.”

On Friday, a huge controversy broke out in Tamil Nadu over the three language formula with political parties warning a language war over “attempts” to impose Hindi, even as the Centre stepped in to say that there was no intention to impose any language on anyone.

However, as the controversy snowballed, the Centre dismissed apprehensions on the issue and said there was no move to impose any language on anyone.

Also read: In Mumbai, women stand with police all night to keep roads safe

“Only a report has been submitted on the new education policy. Government has not taken any decision on it. It has not even considered it and therefore the misunderstanding that the government has decided on the new education policy is not true,” Information and Broadcasting Minister Prakash Javadekar told the media.

“After we will get the public feedback, then only it will come up before the government. More importantly, the Modi government has always promoted all Indian languages and therefore there is no case of or intention of imposing any language on anybody. We want to promote all Indian languages,” he said.

The draft of New Education Policy prepared by the Kasturirangan Committee was released on Friday, which spoke of the continuation of three-language formula in the schools.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 11,2020

New Delhi, Mar 11: According to the Union health ministry, there are 62 confirmed cases of coronavirus in the country.

The Delhi High Court Wednesday sought the stand of the Centre and the Delhi government on a PIL seeking proper and adequate measures to combat coronavirus.

A bench of Chief Justice D N Patel and Justice C Hari Shankar issued notice to the Ministry of Health and the Delhi government seeking their replies on the public interest litigation (PIL) filed by an advocate.

The petition, by lawyer Triveni Potekar, seeks directions to the Centre and the Delhi government to make available important and relevant information on access to and availability of medical facilities for testing and treatment for the coronavirus disease.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 22,2020

Mumbai, May 22: The Reserve Bank of India (RBI) on Friday reduced repo rate by 40 basis points to 4 per cent in an effort to further boost liquidity in the economy which has been reeling under the impact of COVID-19 induced countrywide lockdown.

As a result, the reverse repo rate stands at 3.35 per cent, said RBI Governor Shaktikanta Das. The six-member monetary policy committee (MPC) voted 5:1 in favour of the decision.

Repo rate is the rate at which a country's central bank lends money to commercial banks, and the reverse repo rate is the rate at which it borrows from them. 

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.